Trial Details

TERMINATED
Basic Information
Clinical ID c1111
Identifier NCT00317356
Trial Title A Dose-finding Study of OPC-6535 in Patients With Active Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Colitis, Ulcerative
Interventions DRUG: OPC-6535(Tetomilast)
Participant Information
Sponsor Otsuka Pharmaceutical Co., Ltd.
City Chubu Region
Country/Region Japan
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2025-05-06
Primary Completion Date 2025-08-07
Completion Date 2025-08-07